Loading data
XGNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 66.58 m USD | 55.64 m USD | 52.55 m USD | 45.56 m USD | 48.3 m USD |
| Cost of revenue | 27.78 m USD | 22.53 m USD | 23.09 m USD | 24.21 m USD | 20.59 m USD |
| Gross profit | 38.8 m USD | 33.11 m USD | 29.46 m USD | — | — |
| Research and development expense | 6.25 m USD | 5.38 m USD | 4.87 m USD | 9.88 m USD | 7.24 m USD |
| Selling, general and administrative expense | 46.62 m USD | 41.37 m USD | 47.43 m USD | 52.02 m USD | 44.54 m USD |
| Operating profit | -14.07 m USD | -13.64 m USD | -22.84 m USD | -46.05 m USD | -24.07 m USD |
| Interest expense | — | — | 2.34 m USD | 2.45 m USD | 2.63 m USD |
| Income tax expense | 51 k USD | 12 k USD | 33 k USD | -282 k USD | 175 k USD |
| Net income (reported basis) | -19.95 m USD | -15.12 m USD | -23.69 m USD | -47.39 m USD | -26.85 m USD |
| Basic earnings per share | -0.93 USD/share | -0.83 USD/share | -1.34 USD/share | -2.77 USD/share | -1.68 USD/share |
| Diluted earnings per share | -0.93 USD/share | -0.83 USD/share | -1.34 USD/share | -2.77 USD/share | -1.68 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.